 | • レポートコード：20QY06-01230 • 出版社/出版日：QYResearch / 2020年6月1日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、148ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社の当調査資料では、オピオイド薬のグローバル市場について種類別（オキシコドン、ハイドロモルホン、コデイン、フェンタニル、その他）、用途別（鎮痛、麻酔、その他）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。 ・オピオイド薬市場の概要 ・世界の主要地域別オピオイド薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のオピオイド薬市場規模2015-2026：種類別（オキシコドン、ハイドロモルホン、コデイン、フェンタニル、その他） ・世界のオピオイド薬市場規模2015-2026：用途別（鎮痛、麻酔、その他） ・オピオイド薬の北米市場規模2015-2020 ・オピオイド薬のヨーロッパ市場規模2015-2020 ・オピオイド薬の中国市場規模2015-2020 ・オピオイド薬の日本市場規模2015-2020 ・オピオイド薬の東南アジア市場規模2015-2020 ・オピオイド薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 （Teva、Purdue Pharma、Mallinckrodt、Amneal Pharma、Collegium、J&J、Endo、Pfizer、INSYS、Mylan、Hikma、Egalet） ・オピオイド薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・オピオイド薬の市場動向・機会・課題 ・調査の結論 |
Opioids are a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others. These drugs are chemically related and interact with opioid receptors on nerve cells in the body and brain.
The classification of Opioids Drug includes Oxycodone, Hydromorphone, Codeine, Fentanyl and Other, and the revenue proportion of Oxycodone in 2016 is about 33%, and the proportion is in decreasing trend from 2012 to 2016.
Opioids Drug is widely used for Pain Relief, Anesthesia and Other. The most proportion of Opioids Drug is for Pain Relief, and the proportion in 2016 is about 66.5%.
North America is the largest supplier of Opioids Drug, with a production market share nearly 71% in 2016. Europe is the second largest supplier of Opioids Drug Media, enjoying production market share nearly 16% in 2016.
North America is the largest consumption place, with a consumption market share nearly 60.5 % in 2016. Following North America, Europe is the second largest consumption place with the consumption market share of 20%.
Market competition is not intense. Purdue Pharma, J&J, Teva, Mylan, etc. are the leaders of the industry, and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Opioids Drug Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Opioids Drug market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Opioids Drug industry.
Based on our recent survey, we have several different scenarios about the Opioids Drug YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 10440 million in 2019. The market size of Opioids Drug will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Opioids Drug Scope and Market Size
The global Opioids Drug market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Opioids Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Opioids Drug market is segmented into
Oxycodone
Hydromorphone
Codeine
Fentanyl
Other
Segment by Application, the Opioids Drug market is segmented into
Pain Relief
Anesthesia
Other
The Opioids Drug market is analysed and market size information is provided by regions (countries). Segment by Application, the Opioids Drug market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Opioids Drug Market Share Analysis
Opioids Drug market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Opioids Drug business, the date to enter into the Opioids Drug market, Opioids Drug product introduction, recent developments, etc.
The major vendors covered:
Teva
Purdue Pharma
Mallinckrodt
Amneal Pharma
Collegium
J&J
Endo
Pfizer
INSYS
Mylan
Hikma
Egalet
1 Opioids Drug Market Overview
1.1 Opioids Drug Product Scope
1.2 Opioids Drug Segment by Type
1.2.1 Global Opioids Drug Sales by Type (2020-2026)
1.2.2 Oxycodone
1.2.3 Hydromorphone
1.2.4 Codeine
1.2.5 Fentanyl
1.2.6 Other
1.3 Opioids Drug Segment by Application
1.3.1 Global Opioids Drug Sales Comparison by Application (2020-2026)
1.3.2 Pain Relief
1.3.3 Anesthesia
1.3.4 Other
1.4 Opioids Drug Market Estimates and Forecasts (2015-2026)
1.4.1 Global Opioids Drug Sales Growth Rate (2015-2026)
1.4.2 Global Opioids Drug Revenue and Growth Rate (2015-2026)
1.4.3 Global Opioids Drug Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Opioids Drug Industry Impact
1.5.1 How the Covid-19 is Affecting the Opioids Drug Industry
1.5.1.1 Opioids Drug Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Opioids Drug Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Opioids Drug Players to Combat Covid-19 Impact
2 Opioids Drug Estimate and Forecast by Region
2.1 Global Opioids Drug Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Opioids Drug Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Opioids Drug Sales Market Share by Region (2015-2020)
2.2.2 Global Opioids Drug Revenue Market Share by Region (2015-2020)
2.3 Global Opioids Drug Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Opioids Drug Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Opioids Drug Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Opioids Drug Estimates and Projections (2015-2026)
2.4.2 Europe Opioids Drug Estimates and Projections (2015-2026)
2.4.3 China Opioids Drug Estimates and Projections (2015-2026)
2.4.4 Japan Opioids Drug Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Opioids Drug Estimates and Projections (2015-2026)
2.4.6 India Opioids Drug Estimates and Projections (2015-2026)
3 Global Opioids Drug Competition Landscape by Players
3.1 Global Top Opioids Drug Players by Sales (2015-2020)
3.2 Global Top Opioids Drug Players by Revenue (2015-2020)
3.3 Global Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids Drug as of 2019)
3.4 Global Opioids Drug Average Price by Company (2015-2020)
3.5 Manufacturers Opioids Drug Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Opioids Drug Players (Opinion Leaders)
4 Global Opioids Drug Market Size by Type
4.1 Global Opioids Drug Historic Market Review by Type (2015-2020)
4.1.1 Global Opioids Drug Sales Market Share by Type (2015-2020)
4.1.2 Global Opioids Drug Revenue Market Share by Type (2015-2020)
4.1.3 Global Opioids Drug Price by Type (2014-2020)
4.2 Global Opioids Drug Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Opioids Drug Sales Forecast by Type (2021-2026)
4.2.2 Global Opioids Drug Revenue Forecast by Type (2021-2026)
4.2.3 Global Opioids Drug Price Forecast by Type (2021-2026)
5 Global Opioids Drug Market Size by Application
5.1 Global Opioids Drug Historic Market Review by Application (2015-2020)
5.1.1 Global Opioids Drug Sales Market Share by Application (2015-2020)
5.1.2 Global Opioids Drug Revenue Market Share by Application (2015-2020)
5.1.3 Global Opioids Drug Price by Application (2015-2020)
5.2 Global Opioids Drug Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Opioids Drug Sales Forecast by Application (2021-2026)
5.2.2 Global Opioids Drug Revenue Forecast by Application (2021-2026)
5.2.3 Global Opioids Drug Price Forecast by Application (2021-2026)
3 North America Opioids Drug Market Facts & Figures
3.2 North America Opioids Drug Sales Market Share by Company (2015-2020)
3.3 North America Opioids Drug Sales Market Share by Type (2015-2020)
3.4 North America Opioids Drug Sales Market Share by Application (2015-2020)
4 Europe Opioids Drug Market Facts & Figures
4.2 Europe Opioids Drug Sales Market Share by Company (2015-2020)
4.3 Europe Opioids Drug Sales Market Share by Type (2015-2020)
4.4 Europe Opioids Drug Sales Market Share by Application (2015-2020)
5 China Opioids Drug Market Facts & Figures
5.2 China Opioids Drug Sales Market Share by Company (2015-2020)
5.3 China Opioids Drug Sales Market Share by Type (2015-2020)
5.4 China Opioids Drug Sales Market Share by Application (2015-2020)
6 Japan Opioids Drug Market Facts & Figures
6.2 Japan Opioids Drug Sales Market Share by Company (2015-2020)
6.3 Japan Opioids Drug Sales Market Share by Type (2015-2020)
6.4 Japan Opioids Drug Sales Market Share by Application (2015-2020)
7 Southeast Asia Opioids Drug Market Facts & Figures
7.2 Southeast Asia Opioids Drug Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Opioids Drug Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Opioids Drug Sales Market Share by Application (2015-2020)
8 India Opioids Drug Market Facts & Figures
8.2 India Opioids Drug Sales Market Share by Company (2015-2020)
8.3 India Opioids Drug Sales Market Share by Type (2015-2020)
8.4 India Opioids Drug Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Opioids Drug Business
12.1 Teva
12.1.1 Teva Opioids Drug Corporation Information
12.1.2 Teva Opioids Drug Business Overview and Total Revenue
12.1.3 Teva Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Teva Opioids Drug Products Offered
12.1.5 Teva Recent Development
12.2 Purdue Pharma
12.2.1 Purdue Pharma Opioids Drug Corporation Information
12.2.2 Purdue Pharma Opioids Drug Business Overview and Total Revenue
12.2.3 Purdue Pharma Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Purdue Pharma Opioids Drug Products Offered
12.2.5 Purdue Pharma Recent Development
12.3 Mallinckrodt
12.3.1 Mallinckrodt Opioids Drug Corporation Information
12.3.2 Mallinckrodt Opioids Drug Business Overview and Total Revenue
12.3.3 Mallinckrodt Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Mallinckrodt Opioids Drug Products Offered
12.3.5 Mallinckrodt Recent Development
12.4 Amneal Pharma
12.4.1 Amneal Pharma Opioids Drug Corporation Information
12.4.2 Amneal Pharma Opioids Drug Business Overview and Total Revenue
12.4.3 Amneal Pharma Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Amneal Pharma Opioids Drug Products Offered
12.4.5 Amneal Pharma Recent Development
12.5 Collegium
12.5.1 Collegium Opioids Drug Corporation Information
12.5.2 Collegium Opioids Drug Business Overview and Total Revenue
12.5.3 Collegium Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Collegium Opioids Drug Products Offered
12.5.5 Collegium Recent Development
12.6 J&J
12.6.1 J&J Opioids Drug Corporation Information
12.6.2 J&J Opioids Drug Business Overview and Total Revenue
12.6.3 J&J Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
12.6.4 J&J Opioids Drug Products Offered
12.6.5 J&J Recent Development
12.7 Endo
12.7.1 Endo Opioids Drug Corporation Information
12.7.2 Endo Opioids Drug Business Overview and Total Revenue
12.7.3 Endo Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Endo Opioids Drug Products Offered
12.7.5 Endo Recent Development
12.8 Pfizer
12.8.1 Pfizer Opioids Drug Corporation Information
12.8.2 Pfizer Opioids Drug Business Overview and Total Revenue
12.8.3 Pfizer Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer Opioids Drug Products Offered
12.8.5 Pfizer Recent Development
12.9 INSYS
12.9.1 INSYS Opioids Drug Corporation Information
12.9.2 INSYS Opioids Drug Business Overview and Total Revenue
12.9.3 INSYS Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
12.9.4 INSYS Opioids Drug Products Offered
12.9.5 INSYS Recent Development
12.10 Mylan
12.10.1 Mylan Opioids Drug Corporation Information
12.10.2 Mylan Opioids Drug Business Overview and Total Revenue
12.10.3 Mylan Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Mylan Opioids Drug Products Offered
12.10.5 Mylan Recent Development
12.11 Hikma
12.11.1 Hikma Opioids Drug Corporation Information
12.11.2 Hikma Opioids Drug Business Overview and Total Revenue
12.11.3 Hikma Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Hikma Opioids Drug Products Offered
12.11.5 Hikma Recent Development
12.12 Egalet
12.12.1 Egalet Opioids Drug Corporation Information
12.12.2 Egalet Opioids Drug Business Overview and Total Revenue
12.12.3 Egalet Opioids Drug Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Egalet Opioids Drug Products Offered
12.12.5 Egalet Recent Development
13 Opioids Drug Manufacturing Cost Analysis
13.1 Opioids Drug Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Opioids Drug
13.4 Opioids Drug Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Opioids Drug Distributors List
14.3 Opioids Drug Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Opioids Drug Sales (M Units) Growth Rate by Type (2020-2026)
Table 2. Global Opioids Drug Sales (M Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Opioids Drug Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Opioids Drug Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Opioids Drug Players to Combat Covid-19 Impact
Table 8. Global Market Opioids Drug Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Opioids Drug Sales (M Units) by Region (2015-2020)
Table 10. Global Opioids Drug Sales Market Share by Region (2015-2020)
Table 11. Global Opioids Drug Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Opioids Drug Revenue Share by Region (2015-2020)
Table 13. Global Opioids Drug Sales (M Units) Forecast by Region (2021-2026)
Table 14. Global Opioids Drug Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Opioids Drug Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Opioids Drug Revenue Share Forecast by Region (2021-2026)
Table 17. Global Opioids Drug (M Units) of Key Companies (2015-2020)
Table 18. Global Opioids Drug Sales Share by Company (2015-2020)
Table 19. Global Opioids Drug Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Opioids Drug Revenue Share by Company (2015-2020)
Table 21. Global Opioids Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioids Drug as of 2019)
Table 22. Global Opioids Drug Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Opioids Drug Manufacturing Sites and Area Served
Table 24. Manufacturers Opioids Drug Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Opioids Drug Players
Table 27. Global Opioids Drug Sales (M Units) by Type (2015-2020)
Table 28. Global Opioids Drug Sales Share by Type (2015-2020)
Table 29. Global Opioids Drug Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Opioids Drug Price (M Units) by Type (2015-2020)
Table 31. Global Opioids Drug Sales Share by Type (2021-2026)
Table 32. Global Opioids Drug Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Opioids Drug Revenue Share by Type (2021-2026)
Table 34. Global Opioids Drug Price (M Units) by Type (2021-2026)
Table 35. Global Opioids Drug Sales (M Units) by Application (2015-2020)
Table 36. Global Opioids Drug Sales Share by Application (2015-2020)
Table 37. Global Opioids Drug Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Opioids Drug Price (M Units) by Application (2015-2020)
Table 39. Global Opioids Drug Sales (M Units) by Application (2021-2026)
Table 40. Global Opioids Drug Sales Share by Application (2021-2026)
Table 41. Global Opioids Drug Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Opioids Drug Revenue Share by Application (2021-2026)
Table 43. Global Opioids Drug Price (M Units) by Application (2021-2026)
Table 44. United States Opioids Drug Sales (M Units) by Company (2015-2020)
Table 45. United States Opioids Drug Sales Market Share by Company (2015-2020)
Table 46. United States Opioids Drug Sales (M Units) by Type (2015-2020)
Table 47. United States Opioids Drug Sales Market Share by Type (2015-2020)
Table 48. United States Opioids Drug Sales (M Units) by Application (2015-2020)
Table 49. United States Opioids Drug Sales Market Share by Application (2015-2020)
Table 50. Europe Opioids Drug Sales (M Units) by Company (2015-2020)
Table 51. Europe Opioids Drug Sales Market Share by Company (2015-2020)
Table 52. Europe Opioids Drug Sales (M Units) by Type (2015-2020)
Table 53. Europe Opioids Drug Sales Market Share by Type (2015-2020)
Table 54. Europe Opioids Drug Sales (M Units) by Application (2015-2020)
Table 55. Europe Opioids Drug Sales Market Share by Type (2015-2020)
Table 56. China Opioids Drug Sales (M Units) by Company (2015-2020)
Table 57. China Opioids Drug Sales Market Share by Company (2015-2020)
Table 58. China Opioids Drug Sales (M Units) by Type (2015-2020)
Table 59. China Opioids Drug Sales Market Share by Type (2015-2020)
Table 60. China Opioids Drug Sales (M Units) by Application (2015-2020)
Table 61. China Opioids Drug Sales Market Share by Application (2015-2020)
Table 62. Japan Opioids Drug Sales (M Units) by Company (2015-2020)
Table 63. Japan Opioids Drug Sales Market Share by Company (2015-2020)
Table 64. Japan Opioids Drug Sales (M Units) by Type (2015-2020)
Table 65. Japan Opioids Drug Sales Market Share by Type (2015-2020)
Table 66. Japan Opioids Drug Sales (M Units) by Application (2015-2020)
Table 67. Japan Opioids Drug Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Opioids Drug Sales (M Units) by Company (2015-2020)
Table 69. Southeast Asia Opioids Drug Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Opioids Drug Sales (M Units) by Type (2015-2020)
Table 71. Southeast Asia Opioids Drug Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Opioids Drug Sales (M Units) by Type (2015-2020)
Table 73. Southeast Asia Opioids Drug Sales Market Share by Application (2015-2020)
Table 74. India Opioids Drug Sales (M Units) by Company (2015-2020)
Table 75. India Opioids Drug Sales Market Share by Company (2015-2020)
Table 76. India Opioids Drug Sales (M Units) by Type (2015-2020)
Table 77. India Opioids Drug Sales Market Share by Type (2015-2020)
Table 78. India Opioids Drug Sales (M Units) by Application (2015-2020)
Table 79. India Opioids Drug Sales Market Share by Application (2015-2020)
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Teva Opioids Drug Product
Table 84. Teva Recent Development
Table 85. Purdue Pharma Corporation Information
Table 86. Purdue Pharma Description and Business Overview
Table 87. Purdue Pharma Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Purdue Pharma Opioids Drug Product
Table 89. Purdue Pharma Recent Development
Table 90. Mallinckrodt Corporation Information
Table 91. Mallinckrodt Description and Business Overview
Table 92. Mallinckrodt Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Mallinckrodt Opioids Drug Product
Table 94. Mallinckrodt Recent Development
Table 95. Amneal Pharma Corporation Information
Table 96. Amneal Pharma Description and Business Overview
Table 97. Amneal Pharma Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Amneal Pharma Opioids Drug Product
Table 99. Amneal Pharma Recent Development
Table 100. Collegium Corporation Information
Table 101. Collegium Description and Business Overview
Table 102. Collegium Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Collegium Opioids Drug Product
Table 104. Collegium Recent Development
Table 105. J&J Corporation Information
Table 106. J&J Description and Business Overview
Table 107. J&J Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. J&J Opioids Drug Product
Table 109. J&J Recent Development
Table 110. Endo Corporation Information
Table 111. Endo Description and Business Overview
Table 112. Endo Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Endo Opioids Drug Product
Table 114. Endo Recent Development
Table 115. Pfizer Corporation Information
Table 116. Pfizer Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Pfizer Description and Business Overview
Table 118. Pfizer Opioids Drug Product
Table 119. Pfizer Recent Development
Table 120. INSYS Corporation Information
Table 121. INSYS Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. INSYS Description and Business Overview
Table 123. INSYS Opioids Drug Product
Table 124. INSYS Recent Development
Table 125. Mylan Corporation Information
Table 126. Mylan Description and Business Overview
Table 127. Mylan Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Mylan Opioids Drug Product
Table 129. Mylan Recent Development
Table 130. Hikma Corporation Information
Table 131. Hikma Description and Business Overview
Table 132. Hikma Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Hikma Opioids Drug Product
Table 134. Hikma Recent Development
Table . Egalet Corporation Information
Table . Egalet Description and Business Overview
Table . Egalet Opioids Drug Sales (M Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Egalet Opioids Drug Product
Table . Egalet Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Opioids Drug Distributors List
Table 143. Opioids Drug Customers List
Table 144. Market Key Trends
Table 145. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Opioids Drug Product Picture
Figure 2. Global Opioids Drug Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Opioids Drug Market Share by Application in 2020 & 2026
Figure 6. Pain Relief Examples
Figure 7. Anesthesia Examples
Figure 8. Other Examples
Figure 9. Global Opioids Drug Sales (M Units) Growth Rate (2015-2026)
Figure 10. Global Opioids Drug Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Opioids Drug Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Opioids Drug Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Opioids Drug Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Opioids Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Opioids Drug Sales (M Units) Growth Rate (2015-2026)
Figure 16. Europe Opioids Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Opioids Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Opioids Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Opioids Drug Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Opioids Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Opioids Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Opioids Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Opioids Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Opioids Drug Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Opioids Drug Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Opioids Drug Players Market Share by Revenue in Opioids Drug 2015 & 2019
Figure 27. Opioids Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Opioids Drug Revenue Share by Type (2015-2020)
Figure 29. Global Opioids Drug Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Opioids Drug Revenue Share by Application (2015-2020)
Figure 31. Global Opioids Drug Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Opioids Drug Sales Market Share by Type in 2019
Figure 33. United States Opioids Drug Sales Market Share by Type in 2019
Figure 34. Europe Opioids Drug Sales Market Share by Company in 2019
Figure 35. Europe Opioids Drug Sales Market Share by Type in 2019
Figure 36. Europe Opioids Drug Sales Market Share by Application in 2019
Figure 37. China Opioids Drug Sales Market Share by Company in 2019
Figure 38. China Opioids Drug Sales Market Share by Type in 2019
Figure 39. China Opioids Drug Sales Market Share by Application in 2019
Figure 40. Japan Opioids Drug Sales Market Share by Company in 2019
Figure 41. Japan Opioids Drug Sales Market Share by Type in 2019
Figure 42. Japan Opioids Drug Sales Market Share by Application in 2019
Figure 43. Southeast Asia Opioids Drug Sales Market Share by Company in 2019
Figure 44. Southeast Asia Opioids Drug Sales Market Share by Type in 2019
Figure 45. Southeast Asia Opioids Drug Sales Market Share by Application in 2019
Figure 46. India Opioids Drug Sales Market Share by Company in 2019
Figure 47. India Opioids Drug Sales Market Share by Type in 2019
Figure 48. India Opioids Drug Sales Market Share by Application in 2019
Figure 49. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. Purdue Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Amneal Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Collegium Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. J&J Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Endo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. INSYS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Hikma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Egalet Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Key Raw Materials Price Trend
Figure 62. Manufacturing Cost Structure of Opioids Drug
Figure 63. Manufacturing Process Analysis of Opioids Drug
Figure 64. Opioids Drug Industrial Chain Analysis
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Figure 67. Porter's Five Forces Analysis
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
オピオイドの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Opioids market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.4% in the forecast period of 2020 to 2025 and will expected to reach USD 16810 million by 2025, from USD 15260 million in 2019. The Opioids market report provides…- 合成オピオイドの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Synthetic Opioids market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Synthetic Opioids market re…
- オピオイド作動薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Opioids Agonist Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.3% in the forecast period of 2020 to 2025 and will expected to reach USD 18590 million by 2025, from USD 16980 million in 2019. The Opioids Agonist …
- 薬物乱用検査サービスの世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Drug of Abuse Testing Services market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.7% in the forecast period of 2020 to 2025 and will expected to reach USD 4790.3 million by 2025, from USD 4313 million in 2019. The Drug of…
- 局所的痛み軽減の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Topical Pain Relief market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.0% in the forecast period of 2020 to 2025 and will expected to reach USD 8328.9 million by 2025, from USD 7115.4 million in 2019. The Topical Pain Rel…